A 2-Day Training Course Delivered By
Dr. Jürgen ParrisiusStefan Fischer

Dr. Jürgen Parrisius & Stefan Fischer

  • Dr. Jürgen Parrisius is a Managing & Founding Partner of the global BD&L advisory firm ActeaVentures GmbH, and formerly held marketing and BD&L positions at Roche, Pfizer and the biotech Cardion. He has been involved in several high-profile transactions and numerous regional and local carve-out deals in Europe, US, China and South East Asia in various therapeutic areas.
  • Stefan Fischer is a Senior Consultant with ActeaVentures GmbH and brings over 25 years hands-on experience in M&A and in- & out-licensing. He was a Global Alliance Director at Roche up to 2001, where he closed 6 deals in 4 years. After Roche, Stefan served as CEO for several biotech companies (Capsant, Mutabilis, FABPharma).


  1. Comprehensive overview of the business development process in the pharma-biotech world.
  2. Analytical toolkit to profile opportunities that will be successful for your company.
  3. Sources and search tips for finding suitable candidates.
  4. Overview of forecasting and valuation approaches, and typical issues in the process.
  5. The pros and cons of different deal structures: JVs, licensing, M&A, etc.
  6. Key success factors and tips for writing a good term sheet and leading the negotiations.
  7. How to manage the contract phase and to avoid the financial and legal pitfalls that can break a deal.

Additional Benefits

  • Capitalise on the vast real-world experience of the experts. Their course is full of examples, practical insights and tips!
  • Network and share experiences with peers from both the pharma and biotech side.


Why You Should Attend

The Content: Business Development in the pharmaceutical industry has become the most significant source of new products for most pharmaceutical companies. It is now conducted throughout every organisation, which requires executives in many disciplines to understand the process. Even executives new in a business development role often have had no formal training. Companies need to have a structured process throughout the organisation to ensure that there is coordination of efforts and alignment of strategy. This course has been written and developed to capture and structure the processes needed to bring about a successful transaction between pharma-pharma and pharma-biotech companies.

The Experts: The combined hands-on experience of Dr. Jürgen Parrisius & Stefan Fischer is enormous, spanning virtually all therapeutic areas, all forms of BD&L deals, all geographical markets, as well as both big pharma and biotech.

The Pharma Business Development Course is the only available public training course delivered by Dr. Jürgen Parrisius & Stefan Fischer on the topic of business development.

Agenda of The Pharma Business Development Course

Important: all hours are noted in CET/Brussels Time, so carefully convert into your local time zone!

Short breaks will be offered throughout the day.

Day 1



Welcome & Audience Expectations (~30 min)


Strategic Challenges for the BusDev Function (~1 h 30 min)

  • Why business development?
  • Industry and technology trends affecting BD
  • Market Access and the immense importance of a product’s clinical benefit – a major issue for BD!
  • Factors that determine the future value of deals
  • Thinking from the perspective of a company’s cash flows


BD’s Role in Product Portfolio Optimisation (1 h)

  • The impact of product lifecycles on your product portfolio
  • How BD can best contribute
13:00Lunch Break


Profiling Your Ideal Opportunities (~2 h)

  • Internal & external influencing factors
  • Classical vs. Numerical SWOT to quantify and differentiate BD opportunities and gain insight
  • Group Exercise: participants will work in groups on a Numerical SWOT for a real-world case. The interpretation of the results will be discussed in plenary
  • Using the Gap Analysis technique to discriminate between opportunities based on your company’s capabilities
  • Group Exercise: participants will work in groups on a Gap Analysis
  • The Opportunity Anatomy: a technique that leads to a “Perfect Product Profile”


The Search & Evaluation of Opportunities (~1 h)

  • Planning the search process: Who-Where-Criteria
  • How to evaluate whether an opportunity is worthwhile pursuing or not
  • Focus on IP: structure – patent values – issues …
  • Definition and characteristics of the Target Product Profile


Close of Day 1


Day 2



Valuing the Opportunity (~2 h)

  • Sales forecasting: models – pitfalls – issues
  • Valuation tools (i.e. NPV, IRR, Monte Carlo etc.): their logic and application issues
  • From forecast to risk adjusted NPV
  • Group Exercise: in smaller groups, participants work on an r-NPV calculation
  • Company valuations
  • The risk/return elements of a valuation: sources of funds – equity – banks - …
  • The implications of pricing & reimbursement on valuing BD transactions
  • Market distortions caused by government interventions: orphan status, pediatric studies, ...


Negotiating the Deal (~1 h 30 min)


  • Critical elements of the term sheet
  • Key success factors in negotiation
  • Negotiation process and tactics
  • Deal components and contract drafting
13:00Lunch Break


Financial & Legal Success Factors (~1 h 30 min)

  • The final contract: what it should include to avoid problems post-signing
  • Dispute resolution


Alliance Management (~1 h)

  • Different types of alliances
  • Key success factors in Alliance Management
  • Failure factors in Alliance Management


Q&A (30 min)



>> Click here if you wish to receive the PDF brochure of this course

Learning Methodology

The experts optimally balance theory with short exercises and numerous anecdotes that illustrate the theory. The strength of this course lies in providing a comprehensive overview of the business development process, illustrated by many examples from the vast experience of the experts, as well as the many checklists and decision support techniques & tools that can be used in each step.

One of the most valuable aspects of attending any CELforPharma course is not only being able to have your specific questions answered by a leading expert, but also having the opportunity to share experiences and have in-depth discussions with your international peers.

infoThe typical audience size of our courses ranges from 6 to 24 (max) participants.

Who Should Attend?

The Pharma Business Development Course has proven to be a very successful introductory course for two categories of executives:

  • Mid to senior level executives in small pharma and biotech companies with limited formal training in business development but whose role increasingly involves business development activities.
  • Junior to mid-level managers contributing to the business development process in the headquarters of midsize and big pharma companies (e.g. technology assessment, business intelligence…) who need a better understanding of the complete business development process.

Managers in local marketing organisations with responsibility for business development in national markets will also benefit but they should be aware that the course content is geared towards international licensing and acquisition BD responsibilities.

Executives working in generics companies should be aware that the content of this course concentrates on business development deals involving branded pharmaceuticals.

As this course is delivered by Dr. Jürgen Parrisius & Stefan Fischer of global BD&L advisory firm ActeaVentures GmbH, executives from other professional service agencies should request approval prior to registering for this course. Please contact Annelies Swaan, Director Business Operations, for more information (aswaan@celforpharma.com, tel +32 (0)2 709 01 42).


Past Participants

Below is a non-exhaustive list of past participants who have benefited from attending this course.


Job Title



New Business Development ManagerAbbottFrance
Director, Global Forecasting and Commercial AnalyticsAbbvieUSA
Director Business DevelopmentAcino PharmaSwitzerland
Licensing and Contract Marketing ManagerActavisSerbia
Manager, Corporate Business Development, Licensing, Gastrointestinal & PainAlmirallSpain
Bussines Development & Licensing ManagerBayer Healthcare PharmaceuticalsRussian Federation
General ManagerEgisBulgaria
Manager Business DevelopmentFresenius KabiGermany
Financial Project Evaluation ManagerGaldermaFrance
Director, Business DevelopmentGlaxoSmithKlineBelgium
Strategic Marketing ManagerHelsinnSwitzerland
Associate Director Program Manager Research & Early DevelopmentJanssenBelgium
Senior Director, Head of R&D Quality & Compliance Business DevelopmentJohnson & JohnsonNetherlands
Medical DirectorLEO PharmaSwitzerland
ITB France SupervisorMedaFrance
Junior Manager Business DevelopmentMundipharmaGermany
Director Strategic PlanningNovartisSwitzerland
Business Development DirectorOrionFinland
International Product Manager EMEAOrphan EuropeFrance
Business Development Lead - Africa & Middle East RegionPfizerUnited Arab Emirates
Strategic Partnering AssociateRocheSwitzerland
Strategic Portfolio ManagerRoche DiagnosticsSwitzerland
Business Development & New Product Planning ExecutiveSanofiUnited Kingdom
Business Development DirectorServierRussian Federation
BD Project LeaderStallergenesFrance
Regional Medical Director Emerging Markets, Global Medical AffairsTakedaSwitzerland
Director, Specialty Life Cycle Initiatives Global Specialty MedicinesTevaBelgium
Associate Director, Global Market Access & Pricing CNSUCBBelgium
Market Research & Alliance ManagerVifor PharmaSwitzerland
Licensing and Business Development SpecialistZambonItaly



Dates & Locations

Currently all CELforPharma courses are planned to only be held live online (hosted in Zoom) until international travel is back to normal.​​​​

  • 9-10 June 2021, live online

  • 5-6 October 2021, live online

  • 30 November - 1 December 2021, live online

Included in the Registration Fee​

  • Access to an expert led course in real-time, using an interactive platform for break-out rooms, whiteboard exercises, polling, plenary discussions and chats.
  • Course material, which will be provided to you in both digital format (by email) and in hard copy (by post, so you can make notes during the course).
  • Certificate of attendance signed by the experts and CELforPharma.


Group Discounts

Team discounts can be offered to 3 or more delegates from the same company.
Contact Annelies Swaan, Director Business Operations, (aswaan@celforpharma.com) for more details.


How to Register

  1. Click the "Register Here" button on this page.
  2. Choose a course date, then fill out your personal details and company / invoicing details.
  3. Choose to pay via bank transfer or by credit card.
  4. Click "Confirm Registration". You will be sent an automatic email confirming your registration followed by a personal email containing an invoice and further payment instructions.

For assistance in registering, raising a PO or invoicing, please do not hesitate to contact Kealeigh Steel.
(email: kealeigh.steel@celforpharma.com or call: +32 2 709 01 45)


Transfer & Cancellation Policy

Flexible Transfer

  • If a registrant cannot attend the scheduled course, he/she can avoid any cancellation charge by sending a suitable replacement participant.
  • Alternatively, the registrant can transfer once at no extra cost, until 3 weeks prior to the event, to another course held within one year of the original course date.

Participant Cancellation

  • Up to 6 weeks prior to the course: cancellation fee of € 400 per participant.
  • Up to 5 weeks prior to the course: 25% of the invoiced registration fee.
  • Up to 4 weeks prior to the course: 50% of the invoiced registration fee.
  • Up to 3 weeks prior to the course: 75% of the invoiced registration fee.
  • Fewer than 3 weeks or if no notification received: registrant liable to pay invoiced registration fee.
  • If a registrant postpones his/her participation to a future course, and cancels again, no refund can be claimed for registration fees.

Related Courses